The World Health Organization (WHO) has listed two versions of the AstraZeneca/Oxford Covid-19 vaccine for emergency use including the one produced by the Serum Institute of India.
The health experts said that based on studies and research issued by the World Health Organisation (WHO), it indicates that people who received a booster dose were less infected than those who did not receive the booster dose even if they were exposed to mild symptoms.
The jab, produced by Serum Institute of India under licence from the US-based Novavax, will now be distributed as part of global vaccine-sharing system Covax, "giving a much-needed boost to ongoing efforts to vaccinate more people in lower-income countries", WHO said in a statement.
The long-acting antibody medication is designed to prevent severe infection and death amongst immunocompromised patients.
Prof. Sarah Gilbert, one of the scientists behind the Oxford-AstraZeneca COVID-19 vaccine, is warning that the next pandemic may more contagious and more lethal unless more money is devoted to research and preparations to fight emerging viral threats.
"The Kingdom of Saudi Arabia has granted approval for entry of individuals vaccinated with the Russian Sputnik V vaccine starting from Jan.1, 2022," the Russian Direct Investment Fund (RDIF), which financed the development of Sputnik V, said in a statement.
The initiative aims to ensure the senior citizens who are unable to visit medical centres have easy access to the vaccine.
South Africa has suspended AstraZeneca vaccine drive after a small clinical trial suggested that it isn't effective in preventing mild to moderate illness from the variant dominant in the country.
The Dubai Health Authority (DHA) announced on Wednesday that it has started providing the Oxford-AstraZeneca COVID19 vaccine to certain group of people in Dubai.
The US Centers for Disease Control and Prevention (CDC) said on Wednesday the vaccines have been shown to prevent symptomatic COVID-19, thought to play a greater role in the transmission of the virus than asymptomatic disease.